Total Payments
$4,904
2024 Payments
$2,872
Companies
28
Transactions
249
Payment Breakdown by Category
Food & Beverage$4,904 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,904 | 249 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $636.96 | 30 | $0 (2024) |
| Biogen, Inc. | $631.44 | 17 | $0 (2024) |
| EMD Serono, Inc. | $467.78 | 30 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $463.26 | 28 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $445.70 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $337.86 | 27 | $0 (2024) |
| ABBVIE INC. | $279.01 | 9 | $0 (2024) |
| Neurelis, Inc. | $274.48 | 11 | $0 (2024) |
| Celgene Corporation | $228.06 | 19 | $0 (2024) |
| SK Life Science, Inc. | $163.74 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,872 | 143 | UCB, Inc. ($396.69) |
| 2023 | $2,032 | 106 | Neurocrine Biosciences, Inc. ($293.42) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Neurology | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: Neurology | ||||||
| 11/07/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.93 | General |
| Category: Neuroscience | ||||||
| 11/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $5.96 | General |
| 11/05/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/30/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $97.17 | General |
| Category: Neurology | ||||||
| 10/30/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Neurology | ||||||
| 10/29/2024 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $43.25 | General |
| 10/28/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $1.87 | General |
| 10/25/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: Neurology | ||||||
| 10/23/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $6.47 | General |
| 10/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.28 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: Neurology | ||||||
| 10/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Neuropsychiatry | ||||||
| 10/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: Neuropsychiatry | ||||||
| 10/18/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Neurology | ||||||
| 10/14/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $19.10 | General |
| 10/09/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: Neurology | ||||||
| 10/08/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: Neurology | ||||||
| 10/02/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Neuroscience | ||||||
| 10/01/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Rare Disease | ||||||
About Maureen Akaba
Maureen Akaba is a Family healthcare provider based in Southfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2022. The National Provider Identifier (NPI) number assigned to this provider is 1760103907.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Maureen Akaba has received a total of $4,904 in payments from pharmaceutical and medical device companies, with $2,872 received in 2024. These payments were reported across 249 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,904).
Ad
Practice Information
- Specialty Family
- Location Southfield, MI
- Active Since 09/06/2022
- Last Updated 09/06/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1760103907
Products in Payments
- Briviact (Drug) $481.01
- INGREZZA (Drug) $367.74
- KESIMPTA (Drug) $337.86
- VALTOCO (Drug) $274.48
- Austedo XR (Drug) $263.15
- TYSABRI (Biological) $239.73
- ZEPOSIA (Drug) $228.06
- UBRELVY (Drug) $190.40
- AJOVY (Biological) $182.55
- VUMERITY (Drug) $163.46
- MAVENCLAD (Drug) $159.73
- Nayzilam (Drug) $155.95
- AVONEX (Biological) $129.85
- Leqembi (Drug) $116.06
- ULTOMIRIS (Biological) $100.44
- Ongentys (Drug) $95.52
- QULIPTA (Drug) $88.61
- RYTARY (Drug) $81.34
- VYEPTI (Biological) $72.19
- ONPATTRO (Drug) $61.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Southfield
Patricia Krause, Cnp, CNP
Family — Payments: $4,281
Family $4,281
Anita Effinger, Fnp, FNP
Family — Payments: $4,217
Family $4,217
Dr. Ruby Nzoma, Fnp, FNP
Family — Payments: $2,762
Family $2,762
Susan Markowicz, Fnp, Bc, FNP, BC
Family — Payments: $2,543
Family $2,543
Theresa Owusu-Ansah, Np, NP
Family — Payments: $2,191
Family $2,191
Makula Brown, Fnp-C, FNP-C
Family — Payments: $2,003
Family $2,003